Results 71 to 80 of about 15,109,420 (166)

Role of mitochondria-targeting miRNAs in non-alcoholic fatty liver disease

, 2020
Non-alcoholic fatty liver disease (NAFLD) comprises a range of liver lesions from simple steatosis to non-alcoholic steatohepatitis (NASH) and remains a major cause of mortality when progressing to cirrhosis and hepatocellular carcinoma (HCC).
Simão, André Daniel Lopes
core  

Characterization of the gut mycobiome in patients with non-alcoholic fatty liver disease and correlations with serum metabolome

BMC Microbiology
Background Emerging evidence suggests that the gut microbiome plays a key role in metabolic diseases such as non-alcoholic fatty liver disease, yet the contribution of the gut mycobiome remains largely overlooked.
Ning Zheng, Dangrang Wang, Guorui Xing, Yidan Gao, Shenghui Li, Jin Liu, Jian Kang, Shanshan Sha, Lin Cheng, Shao Fan, Jian Yu, Qiulong Yan, Chunmeng Jiang   +12 more
doaj   +1 more source

Management of Cardiovascular Risk in the Non‑alcoholic Fatty Liver Disease Setting

Non-alcoholic fatty liver disease (NAFLD) is an overlooked and undetected pathology, which affects more than 32% of adults worldwide. NAFLD is becoming more common in Western industrialised countries, particularly in patients with central obesity, type 2
Castilla Guerra, Luis, Luque Linero, Paula   +1 more
core   +1 more source

Iron and non-alcoholic fatty liver disease [PDF]

, 2016
The mechanisms that promote liver injury in non-alcoholic fatty liver disease (NAFLD) are yet to be thoroughly elucidated. As such, effective treatment strategies are lacking and novel therapeutic targets are required.
Britton, Laurence J., Subramaniam, V. Nathan, Crawford, Darrell H.G., Crawford, Darrell H. G.   +3 more
core   +1 more source

CMFRI develops seaweed-based product to fight non-alcoholic fatty liver The Hindu dated 21st December 2022 [PDF]

, 2022
The CMFRI signed a memorandum of understanding (MoU) with Emineotech, a private limited company dealing with health products, for commercial production and marketing of patent-protected Nutraceutical developed by the ICAR-Central Marine Fisheries ...
CMFRI, Library
core  

Non-alcoholic fatty liver disease in the practice of a primary care pediatrician

Лечащий Врач
Background. Non-alcoholic fatty liver disease is one of the main multidisciplinary problems in pediatrics. Approximately one in 3-4 people in the population has non-alcoholic fatty liver disease.
L. M. Gordienko, A. A. Vyalkova, L. V. Kutsenko, N. N. Kozhevnikova, D. M. Galaktionova   +4 more
doaj   +1 more source

Relationship between portal chronic inflammation and disease severity in paediatric non-alcoholic fatty liver disease

, 2011
Background: The non-alcoholic steato-hepatitis Clinical Research Network has recently shown that portal chronic inflammation is associated with liver fibrosis in American children with non-alcoholic fatty liver disease.
Comparcola D, Manco M, Comparcola D., De Vito R, Alisi A., Alisi A, Bedogni G, Manco M., Bedogni G., Nobili V., De Vito R.   +10 more
core   +1 more source

Effects of sex and race on the changes in intrahepatic lipid, total and visceral adipose tissue in response to exercise training in obese adolescents [PDF]

, 2013
BACKGROUD: Non-alcoholic fatty liver is the most frequent liver abnormality observed in obese children and adolescents. It is has yet to be determined whether sex and race plays a role in the effect of regular exercise without calorie restriction on ...
Deldin, Anthony
core  

Targeting liver cell metabolism and function in non-alcoholic fatty liver disease

, 2021
Non-alcoholic fatty liver disease (NAFLD) comprises a series of liver lesions ranging from simple steatosis to non-alcoholic steatohepatitis (NASH) and is a major cause of chronic liver disease that may progress to cirrhosis and hepatocellular carcinoma.
Islam, Tawhidul
core  

Adipose Tissue, Metabolic Syndrome, and Non-Alcoholic Fatty Liver Disease – A Short Review [PDF]

, 2014
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease globally, and it is expected to rise even further as a result of the increase in obesity and related risk factors.
Pampaka, Despina, Andrie G Panayiotou, Despina Pampaka, Panayiotou, Andrie, Panayiotis Kouis, Kouis, Panagiotis   +5 more
core